baber/WOPTO huggingface dataset:
Patent AT-E208447-T1 (AT)
Inventor: FABER ATE
IPC: D21H17/28
Filed: 1996-04-10
Granted: 2001-11-15
Abstract: The invention relates to a method for surface sizing paper, wherein an aqeous solution of a degraded amylopectin potato starch is applied to the paper and the sized paper is thereafter dried. The invention also relates to sized paper with the layer of size consisting entirely or substantially entirely of degraded amylopectin potato starch. The amylopectin potato starch may have been isolated from potatoes originating from potato plants obtained through mutation or antisense inhibition.
Patent AT-E230513-T1 (AT)
Inventor: MECCA CHARLES M J
IPC: G11B7/24
Filed: 1996-09-02
Granted: 2003-01-15
Abstract: An improved light-readable information recording disc (1) is provided in which the optical data storage structure consists of either lands (3, 3', 3") and pits (4, 4') or lands and bumps (3, 3' 3") in which the depth of the pits or the height of the bumps respectively, is controlled to approximate one-half of the wavelength of the light striking the optical data storage structure. Unexpected and surprising improvements over conventional optical recording discs is achieved through increased light intensity differences detected at the changeover between pits/bumps and lands. <IMAGE>
Patent AT-E285711-T1 (AT)
Inventor: POWERS JEFFRY EARL
IPC: A61B8/00
Filed: 1996-10-09
Granted: 2005-01-15
Abstract: Apparatus and methods are disclosed for the detection and imaging of ultrasonic contrast agents. Ultrasonic apparatus is provided for coherent imaging of ultrasonic contrast agents, and for detecting harmonic contrast agents. The inventive apparatus includes a dual display for simultaneously viewing a real time image which displays the location of the contrast agent and a triggered contrast image. Methods of contrast agent detection and imaging include the measurement of perfusion rate characteristics, multizone contrast imaging, multifrequency contrast imaging, tissue perfusion display, and high PRF contrast image artifact elimination.
Patent AT-E211060-T1 (AT)
Inventor: RINGOT JEAN-MARC
IPC: B31F1/20
Filed: 1996-03-08
Granted: 2002-01-15
Abstract: The packaging in wide longitudinal sheets is made of a reinforcing sheet (3) with saw tooth fluting and a cover sheet (2). To manufacture the reinforcing sheet a pressurised gas flow (6), from a compression chamber (4), is applied on the sheet surface to press it against a fluted support surface (5). A compression gutter (12), supplied with pressurised and humidified air (13), applies the cover sheet against the reinforcing sheet. Rollers (11) lead and guide the cover sheet to and from the gutter. A paster (8) coated with glue (10) assembles the cover and reinforcing sheets along one of their faces.
Patent AT-E230609-T1 (AT)
Inventor: MCFADDEN D GRANT
IPC: C12N15/09
Filed: 1996-03-26
Granted: 2003-01-15
Abstract: Compositions and methods for treating inflammatory cell infiltration in a tissue of a mammalian subject are provided. The method involves administering a therapeutically effective amount of SERP-1, SERP-1 analog or biologically active fragment thereof admixed with a pharmaceutically acceptable carrier to a subject in need of such treatment. Biologically active SERP-1 analogs are also provided. The compositions and methods of the present invention are useful for treating numerous inflammatory based diseases and injuries.
Patent AT-E225652-T1 (AT)
Inventor: YAYON AVNER
IPC: C12N15/09
Filed: 1996-06-12
Granted: 2002-10-15
Abstract: The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.
Patent AT-E225194-T1 (AT)
Inventor: CARLSSON PER-OLOV
IPC: A61M1/14
Filed: 1996-07-03
Granted: 2002-10-15
Abstract: PCT No. PCT/SE96/00897 Sec. 371 Date Apr. 27, 1998 Sec. 102(e) Date Apr. 27, 1998 PCT Filed Jul. 3, 1996 PCT Pub. No. WO97/02056 PCT Pub. Date Jan. 23, 1997A device in a dialysis machine for exchangeable connection of a powder cartridge (11) between an inlet (56') and an outlet (56) for liquid. The inlet and the outlet are provided in one and the other, respectively, of two jaws (12, 14), and at least one of these is guided for linear displacement towards and away from the other one for engaging the jaws with the powder cartridge (11) under connection of the inlet and the outlet to a hollow stud (18, 19; 31) on the powder cartridge positioned between the jaws for conducting liquid through the cartridge, or for interengaging of the jaws for short circuit of the inlet and the outlet.
Patent AT-E253387-T1 (AT)
Inventor: SIMS NATHANIAL M
IPC: A61M5/145
Filed: 1996-08-23
Granted: 2003-11-15
Abstract: A syringe driver device is able to effect the controlled, parenteral infusion of a medical fluid using an available disposable syringe. The driver device includes a frame heaving a movable carriage, which houses a force applying element, mounted thereto. A disposable syringe mounts upon the frame and a lengthy microbore tubing attaches to the outlet tip of the syringe. As a force is applied to the syringe plunger, fluid is expelled from the syringe, but its flow rate is dependent upon the diameter of the microbore tubing. The driver device enables the delivery of multiple, sequential doses of fluid.
Patent AT-E207129-T1 (AT)
Inventor: DEBATIN KLAUS-MICHAEL
IPC: C12N15/09
Filed: 1996-11-27
Granted: 2001-11-15
Abstract: PCT No. PCT/DE96/02274 Sec. 371 Date Oct. 21, 1998 Sec. 102(e) Date Oct. 21, 1998 PCT Filed Nov. 27, 1996 PCT Pub. No. WO97/20067 PCT Pub. Date Jun. 5, 1997The present invention relates to a process for quantitatively determining CD95 ligand, comprising the following processing steps: (a) isolation of total RNA from cells, (b) transcription the total RNA from (a) into cDNA by reverse transcription, and (c) amplification of the cDNA from (b) and a CD95 ligand competitor fragment by CD95 ligand-specific primers in a PCR reaction. The process is suitable for determining the extent and/or course of apoptosis.
Patent AT-E244339-T1 (AT)
Inventor: BOTICKI JOHN A
IPC: E03C1/10
Filed: 1997-01-15
Granted: 2003-07-15
Abstract: Disclosed is an improved device (10) for preventing back flow of possibly-contaminated water into a potable water system. The device (10) includes first, second and third nozzles (33, 35, 37) in series flow relationship, and an air gap (49) between the first and second nozzles (33, 35). In the improvement, the air gap (49) is a primary air gap and the device (10) includes a secondary air gap (19) fixed with respect to the second nozzle (35). In a more specific aspect of the new device (10), the second and third nozzles (35, 37) are in a tubular housing (41) and the device (10) includes a containment bowl (21) around the housing (41). The secondary air gap (19) includes an aperture (53) in the housing wall (55) and such aperture (53) opens to the containment bowl (21). Other aspects of the new device (10 involve particular nozzle configurations and relationships and a restrictor (103) inhibiting back flow. <IMAGE>
Patent AT-E184588-T1 (AT)
Inventor: JACKSON BARRY DR
IPC: B01J31/02
Filed: 1997-03-12
Granted: 1999-10-15
Abstract: Production of pure alkyl alkylacetoacetate of formula CH3COCH((CH2)2R1)COOR2 (I) from a mixture of (I) and an alkyl alkenylacetoacetate (II) of formula CH3COCH(CH=CHR1)COOR2 or CH3COC(=CHCH2R1)COOR2 and optionally additional byproducts comprises reaction with an alkyl acetoacetate of formula CH3COCH2COOR2 (III) in the presence of a strong base and isolation of the intermediate formed between (II) and (III). R1 = 1-10C alkyl; R2 = 1-4C alkyl.
Patent AT-E435514-T1 (AT)
Inventor: KIENZLER GERHARD
IPC: H02K5/173
Filed: 1997-04-29
Granted: 2009-07-15
Abstract: An electric motor (10) has a housing (12) enclosing a rotor which rotates within a stator and which has a rotor shaft (14) passing centrally through the stator and mounted at its ends in bearings (18, 19), the novelty being that a radial force is applied from one side onto one end (15) of the rotor shaft (14). Preferably, the force is applied by a spring (20) with a metal or plastic leaf spring element (22) which may act indirectly on the shaft via a pressure piece made of wear resistant plastic, especially PTFE or polyamide.
Patent AT-E305113-T1 (AT)
Inventor: MAEKLER KLAUS
IPC: F21S8/00
Filed: 1997-07-12
Granted: 2005-10-15
Abstract: An illumination insert (10) for an installation device, especially a switch or key, comprises an assembly base (12) with a lamp (18) which can be assembled from the front. The insert consists of a dome section (24) which surrounds the lamp (18). The dome is made of a light transparent material, and the dome can be removed from the base if required. The dome preferably consists of polymethacrylate.
Patent AT-E202564-T1 (AT)
Inventor: LESIEUR DANIEL
IPC: A61K31/42
Filed: 1997-11-06
Granted: 2001-07-15
Abstract: Amino methyl heterocyclic derivatives of formula (I), their isomers and salts, are new. R1 = H, 1-6C alkyl or a group of formula (a); m = 1-4; Ar1 = COAr2 or =C-(Ar2)2; Ar2 = phenyl optionally substituted by 1 or more halo, OH, 1-6C alkyl, 1-6C alkoxy or CF3; n = 0-1, A = O or S; X = CH2 or a bond; Y = CH or N; Ar = phenyl or naphthyl (optionally substituted by 1-3 halo, OH, 1-6C alkyl, 1-6C alkoxy, CF3 or aminosulphonyl), pyridyl, pyrimidyl or 3-(benzoÄdÜ-1,2-thiazolyl).
Patent AT-E216257-T1 (AT)
Inventor: THOMAS GRIFFITH R
IPC: C12N15/09
Filed: 1997-01-13
Granted: 2002-05-15
Abstract: The present invention is directed to the surprising and unexpected finding that biologically active thrombopoietin materials can be administered with substantial therapeutic effect at dosage rates commensurate with previously reported administration of such materials, but in a single or low-multiple daily administration. Thus, the predicate of the present invention relates to the reversal of thrombocytopenia by administering to a patient having or in need of such treatment a single or low-multiple daily dose of a therapeutically effective amount of a thrombopoietin. The preferable dose of the active material ranges from about 1 to about 10  mu g/kg body weight.
Patent AT-E219188-T1 (AT)
Inventor: LINDEN ANDERS TOMMY
IPC: D21G9/00
Filed: 1997-03-06
Granted: 2002-06-15
Abstract: An apparatus for removing dust released, for instance, during the production of a soft crepe paper web (1) which is creped off a Yankee cylinder (2) and spread laterally comprises a dust suction box (18) consisting of a housing (20) with an inner suction chamber (21), said housing (20) having a first inlet (24) in the form of a suction gap, a main part (25) and first and second parts (26, 27) which define said suction gap (24) between them. According to the invention the main part is in the form of part of a cylinder to provide a corresponding curved inner side (34) in the suction chamber, and the suction gap comprises an outer gradual throttling (29) and an inner gradual enlargement (30), said throttling and enlargement merging at a transition (31) where said throttling is maximal. The first inlet forming part (26) comprises a flat surface (33) that defines its side of said enlargement whereas the second part (27) forming the inlet comprises both a curved surface (36) having predetermined radius and such an arc length that it defines the whole of its side of the throttling (29) and an initial part of the enlargement (30), and also an inner, flat surface (37) extending at a tangent from the curved surface (36) and forming an acute angle  alpha  with a tangent to the curved surface at said transition.
Patent AT-E244655-T1 (AT)
Inventor: MORSAT PHILIPPE
IPC: B60H1/24
Filed: 1997-11-03
Granted: 2003-07-15
Abstract: The ashtray receptacle (1) includes means for communicating with a suction chamber (2) preferably provided with propeller blades with cutting edges (15) for shredding the cigarette butts and waste. The suction chamber is advantageously connected to means (19) for evacuating smoke outward.
Patent AT-E280979-T1 (AT)
Inventor: VAN DE KERKHOF LEON MARIA
IPC: G11B20/10
Filed: 1997-04-30
Granted: 2004-11-15
Abstract: The transmitter receives the digital information signal with the specific first sampling frequency, and lowpass filters and downpasses the signal to obtain a lowpass filtered version of the signal with a specific second sampling frequency, smaller than the first. A second filter provides digital processomg to the signal, then upsamples (22) the lowpass filtered version to obtain a upsampled version with a third sampling frequency, equal to the first. A third filter (28) filters the upsampled signal to obtain a second filtered version. A signal combiner (20) combines the digital information signal and the second filtered version, to obtain (34) a difference signal. A second combiner combines the lowpass filtered version and the difference signal to obtain a transmission signal, for transmission via the transmission medium.
Patent AT-E213410-T1 (AT)
Inventor: FISCHER WILFRIED
IPC: A61K9/16
Filed: 1997-03-27
Granted: 2002-03-15
Abstract: PCT No. PCT/EP97/01595 Sec. 371 Date May 11, 1999 Sec. 102(e) Date May 11, 1999 PCT Filed Mar. 27, 1997 PCT Pub. No. WO97/35568 PCT Pub. Date Oct. 2, 1997The object of the present invention is an oral drug preparation containing the  gamma -cyclodextrin complex of diclofenac or pharmaceutically acceptable salts thereof, especially the sodium salt prepared by known methods, and by which the gastro-intestinal irritancy of diclofenac, at the same or improved bioavailability, can be considerably decreased.
Patent AT-E439849-T1 (AT)
Inventor: KADIYALA SUDHA
IPC: C12M1/00
Filed: 1997-04-17
Granted: 2009-09-15
Abstract: Disclosed are compositions and methods for augmenting bone formation by administering isolated human mesenchymal stem cells (hMSCs) with a ceramic material or matrix or by administering hMSCs; fresh, whole marrow; or combinations thereof in a resorbable biopolymer which supports their differentiation into the osteogenic lineage. Contemplated is the delivery of (i) isolated, culture-expanded, human mesenchymal stem cells; (ii) freshly aspirated bone marrow; or (iii) their combination in a carrier material or matrix to provide for improved bone fusion area and fusion mass, when compared to the matrix alone. The material or matrix can be a granular ceramic or three-dimensionally formed ceramic implant. The material or matrix can also be a resorbable biopolymer. The resorbable biopolymer is an absorbable gelatin, collagen or cellulose matrix, can be in the form of a powder or sponge, and is preferably a bovine skin-derived gelatin. The implants can be shaped as a cube, cylinder, block or an anatomical site. The compositions and methods can further include administering a bioactive factor such as a synthetic glucocorticoid, like dexamethasone, or a bone morphogenic protein, like BMP-2, BMP-3, BMP-4, BMP-6 and BMP-7.
Patent AT-E238380-T1 (AT)
Inventor: WILKES GARY R
IPC: C08J9/04
Filed: 1997-08-05
Granted: 2003-05-15
Abstract: A propylene homopolymer or copolymer, or a blend thereof, possessing both sufficient strain hardening, viscoelastic behavior, and melt ductility is heated, melted, and mixed in an extruder with an organic or inorganic physical blowing agent, or a mixture of organic and inorganic physical blowing agents, and with optional compatibilizing agents, nucleating agents, stabilizers and miscellaneous additives. This mixture is pressurized and, subsequently, is cooled to an appropriate temperature at an elevated pressure, and is extruded through a die at rates in excess of 1000 kg/hr to produce an expanded and dimensionally-stable, predominately closed cell propylene polymer foam with a density of between 10 kg/m3 and 150 kg/m3, and with a thickness in excess of 1.3 cm. The resultant foamed structure is characterized by a Foamability Index of greater than 1.9 and an Ebullition Time of less than 2.0x10-4 seconds.
Patent AT-E254434-T1 (AT)
Inventor: WALLACE GEORGE
IPC: A61B17/12
Filed: 1997-09-18
Granted: 2003-12-15
Abstract: This invention is a stent (1) and stent catheter (2) for intracranial use. The stent is a rolled sheet stent (20) and is releasably mounted on the distal tip (21) of the catheter by means of a low profile or non-sliding retention and release mechanism. The low profile or non-sliding release mechanism (22) is operated remotely at the proximal end of the catheter by means of a linear translator (23). The stent is rolled tightly on the distal tip of the catheter and flexibility of the tightly rolled stent is promoted by ribbed or slatted construction (or, alternatively, slotted construction) in which the various layers of the stent are provided with numerous slats which counter align when the stent is expanded to form an imperforate wall from a plurality of perforate layers.
Patent AT-E320488-T1 (AT)
Inventor: EL TAYAR NABIL
IPC: C12N15/09
Filed: 1997-11-25
Granted: 2006-04-15
Abstract: The invention concerns a purified polypeptide corresponding to a mutated form of the soluble LAG-3 protein or of one of its fragments comprising the extra-cellular domain D1 and D2.
Patent AT-E208239-T1 (AT)
Inventor: MUELLER ALFRED
IPC: B21B1/18
Filed: 1998-01-19
Granted: 2001-11-15
Abstract: The rod and wire rolling mill includes a cooling bed line (6) for rods, a rotary basket coiling line (7) for coiled rod and a wire line (8) with a coil layer (9) and a coil collector (11) for wire, with keep-warm furnaces for subsequent heat treatment of the products leaving the mill. The lines (6, 7, 8) are joined to a common keep-warm furnace (32) by means of a transport system (25).
Patent AT-E268375-T1 (AT)
Inventor: HUESKENS JUERGEN
IPC: B03B9/06
Filed: 1998-07-02
Granted: 2004-06-15
Abstract: An automatic acquisition and removal apparatus (3) connected to the pre-comminuting apparatus (2) has identifying devices (8, 9) to identify and removal device (10) to remove waste objects containing pollutants, e.g. PVC and paper. The pre-comminuting apparatus (2) is connected though a conveyor belt (7) to the acquisition and removal apparatus (3) to sort the waste objects. Production plant comprises a pre-comminuting apparatus (2), an iron separator (4) and a ring roller press (5). The press is provide with a ring matrix (14) with openings (17) extending radially from the inner side (15) to the outer side (16). An automatic acquisition and removal apparatus (3) connected to the pre-comminuting apparatus (2) has identifying devices (8, 9) to identify and removal device (10) to remove waste objects containing pollutants. The pre-comminuting apparatus (2) is connected though a conveyor belt (7) to the acquisition and removal apparatus (3) to sort the waste objects.
Patent AT-E231426-T1 (AT)
Inventor: HEINEMANN ROLF DIPL-ING
IPC: B22D15/02
Filed: 1998-10-24
Granted: 2003-02-15
Abstract: At least one additional gas inlet channel (34) and one or more additional gas outlet channels (36) are formed between the mold cover core (14) and pressure plug shield (16). A cover (22) is provided inside the pressure plug (24, 26) beneath these additional gas channels, covering the mold cover core and dividing the cavity into top and bottom regions, between which gas can flow. The mold includes a cover core linked to supply lines for pressure-generating gases. A pressure plug shield is placed on top of the cover core to seal off the pressurized gas supply region. The cover core is gas-impermeable in the region where it meets the pressure plug shield.
Patent AT-E287809-T1 (AT)
Inventor: LIOU GAIETER
IPC: B60R25/00
Filed: 1998-10-24
Granted: 2005-02-15
Abstract: A convertible lock structure includes a main body (1) including a lock core (11) received therein and a latch rod (15) extending from an end thereof. The main body includes a transverse hole defined therein for receiving an end of a spring-biased control latch (12). A casing (2) receives the main body (1) and includes an end wall through which the latch rod extends. The casing (2) further includes at least two positioning holes (24a,24b) one of which is selected to receive the second end of the control latch (12). A second end of the control latch (12) is operable by a proper key so as to move between a retracted position inside the main body (1) which allows the main body to move in the casing (2) and an extended position beyond the transverse hole to retain the main body (1) in position. <IMAGE>
Patent AT-E299879-T1 (AT)
Inventor: KUHAR MICHAEL J
IPC: A61K51/00
Filed: 1992-11-13
Granted: 2005-08-15
Abstract: Novel compounds show high affinity for specific cocaine receptors in the brain, particularly dopamine transporter sites, and have the formula Wherein Y = CH<sub>2</sub>R<sub>3</sub>, CO<sub>2</sub>R<sub>2</sub> orR<sub>1</sub> =hydrogen, C<sub>1-5</sub> alkyl,R<sub>2</sub> =hydrogen, C<sub>1-6</sub> alkyl, C<sub>3-8</sub> cycloalkyl, C<sub>1-4</sub> alkoxy, C<sub>1-6</sub> alkynyl, halogen or amine,R<sub>3</sub> =OH, hydrogen, C<sub>1-6</sub> alkyl, C<sub>3-8</sub> cycloalkyl, C<sub>1-4</sub> alkoxy, Cl, Br, I, CN, NH<sub>2</sub>, NHC<sub>1-6</sub> alkyl, NC<sub>1-6</sub> alkyl, OCOC<sub>1-6</sub> alkyl, OCOC<sub>1-3</sub> alkylaryl,A =S, O or NHX =H, C<sub>1-6</sub> alkyl, C<sub>3-8</sub> cycloalkyl, C<sub>1-4</sub> alkoxy, C<sub>1-6</sub> alkynyl, halogen, amino, acylamido, andZ =H, I, Br, Cl, F, CN, CF<sub>3</sub> NO<sub>2</sub>, N<sub>3</sub>, OR<sub>1</sub>, CO<sub>2</sub>NH<sub>2</sub>, CO<sub>2</sub>R<sub>1</sub>, C<sub>1-6</sub> alkyl, NR<sub>4</sub>R<sub>5</sub>, NHCOR<sub>5</sub>, NHCO<sub>2</sub>R<sub>6</sub>, wherein R<sub>4</sub>-R<sub>6</sub> are each C<sub>1-6</sub> alkyl.
Patent AT-E229149-T1 (AT)
Inventor: TUFFE STEPHANE
IPC: F16L37/38
Filed: 1998-10-08
Granted: 2002-12-15
Abstract: The quick connection comprises a tube (14) for an end of a pipe to be connected and a valve pre-loaded by a spring (48) controlled by the introduction and withdrawal of the pipe end into the tube. The valve comprises a first part (32) sliding in the tube on which the pipe end acts. It has a second part (34) which forms the valve itself mounted coaxially with the first part. A spring (42) is provided between the two valve parts. The pre-load spring has a stiffness less than that of the other spring.